Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples | Zendy

Knut Gubbe | Zendy; Yvonne Scharnagl | Zendy; Steffi Grosch | Zendy; Torsten Tonn | Zendy; Michael Schmidt | Zendy; Kai Hourfar | Zendy; Andreas Karl | Zendy; Erhard Seifried | Zendy; Ina Wilkemeyer | Zendy; Ulrich Kalus | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Validation of Virus NAT for HIV, HCV, HBV and HAV Using Post-Mortal Blood Samples

Author(s) -

Knut Gubbe,

Yvonne Scharnagl,

Steffi Grosch,

Torsten Tonn,

Michael Schmidt,

Kai Hourfar,

Andreas Karl,

Erhard Seifried,

Ina Wilkemeyer,

Ulrich Kalus

Publication year - 2012

Publication title -

transfusion medicine and hemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.971

H-Index - 39

eISSN - 1660-3818

pISSN - 1660-3796

DOI - 10.1159/000345319

Subject(s) - nat , coefficient of variation , virology , human immunodeficiency virus (hiv) , blood donor , blood donations , medicine , chromatography , immunology , chemistry , computer network , computer science

Commercial available NAT systems are usually not validated for screening of post-mortem blood samples. NAT testing might be challenging due to inhibitory substances in the cadaveric blood sample that cause false-negative test results. Validation studies have to be performed to show the performance characteristics of the NAT assays for testing cadaveric blood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research